Cutting R&D to Save Innovation | GenomeWeb

The pharmaceutical industry needs help — it is facing drastic cuts in personnel, pipelines drying up, patent cliffs looming, a lack of innovation. Many critics of the pharmaceutical industry say it doesn't help that companies are cutting back on R&D, either. But pharma veteran Bernard Munos says cutting R&D is actually what's going to save the industry, according to Forbes' Matthew Herper.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Tech of the Future

Changes Ahead

20 Science Questions

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.